The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Dose escalation for mitigating diarrhea: Ranked tolerability assessment of anti-diarrheal regimens in patients receiving neratinib for early-stage breast cancer.
 
Gavin M. Marx
Consulting or Advisory Role - Janssen
 
Amy Jo Chien
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Merck (Inst); Puma Biotechnology (Inst); Seagen (Inst)
 
José A. García-Sáenz
No Relationships to Disclose
 
Arlene Chan
Honoraria - Lilly; Novartis
Consulting or Advisory Role - Lilly
Research Funding - Eisai
 
Manuel Ruiz-Borrego
Honoraria - Novartis; pfizer; Roche/Genentech
Consulting or Advisory Role - Puma Biotechnology; Roche
 
Carlos Hernando Barcenas
Speakers' Bureau - Genomic Health
Research Funding - Puma Biotechnology (Inst)
 
Michael P. Thirlwell
No Relationships to Disclose
 
Maureen E. Trudeau
Stock and Other Ownership Interests - RNA Diagnostics
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Eisai (Inst); Genomic Health (Inst); Novartis (Inst); Pfizer (Inst); Roche Canada (Inst)
 
Ron Bose
Research Funding - Puma Biotechnology (Inst)
 
Daniel Egle
No Relationships to Disclose
 
Barbara Pistilli
Consulting or Advisory Role - Myriad Genetics; Novartis; Pierre Fabre; Puma Biotechnology
Research Funding - AstraZeneca (Inst); Daiichi Sankyo (Inst); Merus (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - AstraZeneca; MSD Oncology; Novartis; Pfizer
 
Johanna Wassermann
Honoraria - Amgen; Bayer; Eisai; GlaxoSmithKline; Lilly; Pfizer
 
Kerry A. Cheong
No Relationships to Disclose
 
Dieter Semsek
No Relationships to Disclose
 
Christian F. Singer
No Relationships to Disclose
 
Daniel Hunt
Employment - Puma Biotechnology
Stock and Other Ownership Interests - Puma Biotechnology
 
Utpal Khambholja
Employment - Puma Biotechnology
Stock and Other Ownership Interests - Puma Biotechnology
 
Feng Xu
Employment - Puma Biotechnology
Stock and Other Ownership Interests - Puma Biotechnology
 
Naisargee Shah
Employment - Puma Biotechnology
Stock and Other Ownership Interests - Puma Biotechnology
 
Adam Brufsky
Consulting or Advisory Role - Agendia; Bayer; Bioarray Therapeutics; bioTheranostics; Celgene; Daiichi Sankyo/Lilly; Eisai; Genentech/Roche; Genomic Health; Immunomedics; Lilly; Merck; Myriad Pharmaceuticals; NanoString Technologies; Novartis; Pfizer; Puma Biotechnology; Seagen